| |
| |
|
| Insider
Information: |
Baum Charles M |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
99,550 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$203,967 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
99,550 |
|
|
| Total
Value |
$203,967 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
6
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
6
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-6.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -157.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Mirati Therapeutics, Inc. |
MRTX |
|
2024-01-23 |
0 |
2013-11-26 |
0 |
Premium* |
|
|
Immunomedics Inc |
IMMU |
Director |
2020-10-23 |
0 |
2019-06-07 |
0 |
Premium* |
|
|
Tango Therapeutics Ord Shs |
TNGX |
Director |
2020-09-02 |
40,600 |
|
0 |
Premium* |
|
|
Poseida Therapeutics, Inc. |
PSTX |
|
2023-06-15 |
58,950 |
2022-06-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
55 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TNGX |
Tango Therapeutics Ord Sh... |
Director |
– • – |
2020-09-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
40,600 |
|
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
President & CEO |
• • – |
2019-12-24 |
4 |
OE |
$5.40 |
$7,927 |
D/D |
318 |
56,917 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
President & CEO |
• • – |
2020-04-27 |
4 |
OE |
$5.40 |
$3,008 |
D/D |
557 |
107,023 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
President & CEO |
• • – |
2020-02-28 |
4 |
OE |
$5.40 |
$12,371 |
D/D |
2,291 |
104,175 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
President & CEO |
• • – |
2020-03-27 |
4 |
OE |
$5.40 |
$12,371 |
D/D |
2,291 |
106,466 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
President & CEO |
• • – |
2021-01-26 |
4 |
OE |
$5.40 |
$12,377 |
D/D |
2,292 |
112,714 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
President,Founder,Head of R&D |
• • – |
2022-01-18 |
4 |
S |
$120.48 |
$303,253 |
D/D |
(2,517) |
127,899 |
0 |
% |
|
| MRTX |
Mirati Therapeutics, Inc. |
President & CEO |
• • – |
2021-01-19 |
4 |
OE |
$27.00 |
$87,615 |
D/D |
3,245 |
110,422 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
President & CEO |
• • – |
2019-02-21 |
4 |
OE |
$5.40 |
$78,173 |
D/D |
3,623 |
66,041 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
President,Founder,Head of R&D |
• • – |
2023-01-04 |
4 |
S |
$46.60 |
$169,997 |
D/D |
(3,648) |
168,777 |
0 |
% |
|
| MRTX |
Mirati Therapeutics, Inc. |
President,Founder,Head of R&D |
• • – |
2022-01-18 |
4 |
OE |
$27.00 |
$99,981 |
D/D |
3,703 |
130,416 |
0 |
- |
|
| IMMU |
Immunomedics Inc |
Director |
– • – |
2020-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
3,718 |
13,385 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
President,Founder,Head of R&D |
• • – |
2022-01-04 |
4 |
S |
$147.73 |
$607,855 |
D/D |
(4,114) |
101,170 |
0 |
% |
|
| MRTX |
Mirati Therapeutics, Inc. |
President,Founder,Head of R&D |
• • – |
2023-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
4,444 |
173,221 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
President & CEO |
• • – |
2021-01-06 |
4 |
S |
$210.28 |
$949,066 |
D/D |
(4,511) |
87,512 |
0 |
% |
|
| MRTX |
Mirati Therapeutics, Inc. |
President & CEO |
• • – |
2020-02-04 |
4 |
OE |
$5.40 |
$72,247 |
D/D |
4,687 |
101,884 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
President and CEO |
• • – |
2013-11-26 |
4 |
B |
$16.96 |
$84,819 |
D/D |
5,000 |
5,000 |
2.81 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
President & CEO |
• • – |
2020-07-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
102,023 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
President & CEO |
• • – |
2021-12-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,430 |
105,284 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
President,Founder,Head of R&D |
• • – |
2022-12-21 |
4 |
S |
$40.42 |
$367,469 |
D/D |
(9,092) |
172,425 |
0 |
% |
|
| IMMU |
Immunomedics Inc |
Director |
– • – |
2019-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
9,667 |
9,667 |
0 |
- |
|
| IMMU |
Immunomedics Inc |
Director |
– • – |
2020-10-23 |
4 |
D |
$0.00 |
$0 |
D/D |
(9,667) |
0 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
President & CEO |
• • – |
2019-12-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
56,599 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
President & CEO |
• • – |
2020-12-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
92,023 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
President & CEO |
• • – |
2018-08-24 |
4 |
OE |
$17.41 |
$199,971 |
D/D |
11,486 |
62,418 |
0 |
- |
|
55 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
